My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

Mind Medicine (MindMed) Inc. - Common Shares (NQ:MNMD)

10.88 UNCHANGED

Streaming Delayed Price Updated: 4:00 PM EST, Nov 20, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Mind Medicine (MindMed) Inc. - Common Shares

< Previous 1 2

...

24 25 26 27 28 29 30 31 32

...

34 35 Next >

Psychedelic Stock Gainers And Losers From February 28, 2022 ↗

February 28, 2022

GAINERS: Wellbeing Digital (OTC:

Via Benzinga

Psychedelic & Marijuana Drug Stocks Continue To Decline ↗

February 27, 2022

This article updates the latest stock performances of the 13 clinical-stage companies with the largest market capitalizations which are tracked in the munKNEE Pure-Play Marijuana (4) and the munKNEE...

Via Talk Markets

Field Trip Health, Seelos Therapeutics Among Top Psychedelic Movers Of Today ↗

February 25, 2022

GAINERS: Field Trip Health (NASDAQ:

Via Benzinga

Psychedelic Stock Gainers And Losers From February 24, 2022 ↗

February 24, 2022

GAINERS: Seelos Therapeutics (NASDAQ:

Via Benzinga

MindMed Converts Shares To Have A Single Class ↗

February 23, 2022

Psychedelics-focused biopharma company Mind Medicine Inc. (NASDAQ:

Via Benzinga

Small Pharma, GH Research Among Top Psychedelic Movers Of Today ↗

February 23, 2022

GAINERS: Small Pharma (OTC:

Via Benzinga

Psychedelic Stock Gainers And Losers From February 22, 2022 ↗

February 22, 2022

GAINERS: LOSERS: Mindset Pharma (OTC:

Via Benzinga

Psychedelic & Marijuana Drug Stocks Continued To Decline Last Week ↗

February 21, 2022

An update on the stock performances of the 13 clinical-stage psychedelic and marijuana drug companies with the largest market capitalizations.tttttttttt

Via Talk Markets

Field Trip Health, Mind Medicine Among Top Psychedelic Movers Of Today ↗

February 18, 2022

GAINERS: Field Trip Health (NASDAQ:

Via Benzinga

Psychedelic Stock Gainers And Losers From February 17, 2022 ↗

February 17, 2022

GAINERS: Mindset Pharma (OTC:

Via Benzinga

Cybin, Deepak Chopra Announce Partnership For Psychedelics Awareness And Education ↗

February 15, 2022

Psychedelics-focused biotech company Cybin Inc. (NYSE:CYBN) ...

Via Benzinga

Psychedelic Stock Gainers And Losers From February 15, 2022 ↗

February 15, 2022

GAINERS: Mind Medicine (NASDAQ:

Via Benzinga

Psychedelic Stock Gainers And Losers From February 14, 2022 ↗

February 14, 2022

GAINERS: Wellbeing Digital (OTC:

Via Benzinga

Psychedelic And Cannabis Drug Stocks Continue Advance ↗

February 13, 2022

This article updates the performances of 16 clinical-stage psychedelic and marijuana drug companies researching the treatment of a wide variety of mental illnesses.

Via Talk Markets

Mind Medicine, Cybin Among Top Psychedelic Movers Of Today ↗

February 11, 2022

GAINERS: Revive Therapeutics (OTC: RVVTF) shares closed up 2.51% at $0.22 LOSERS: Mind Medicine (NASDAQ: MNMD) shares closed down 8.09% at $1.25 Cybin (AMEX:CYBN) shares closed down 6.25% at $1.05 ATAI...

Via Benzinga

Allied, Cybin Among Top Psychedelic Movers Of Today ↗

February 10, 2022

GAINERS: Allied (OTC:ALID) shares closed up 7.39% at $1.89

Via Benzinga

Psychedelic Stock Gainers And Losers From February 9, 2022 ↗

February 09, 2022

GAINERS: ATAI Life Sciences (NASDAQ:ATAI) shares closed up 14.29% at $5.76

Via Benzinga

Benzinga's Unprecedented Psychedelics Investing Conference Lands In Miami On April 19th ↗

February 09, 2022

The first Benzinga Psychedelics Capital Conference, the premier gathering of psychedelics industry leaders and forward-thinking investors, is coming to the Fontainebleau Miami Beach on April 19, 2022,...

Via Benzinga

Cathie Wood Is Buying this Peter Thiel-Backed Psychedelics Stock For Ark Funds ↗

February 09, 2022

There’s a new psychedelics company being added to an ETF from Cathie Wood. What Happened: The Ark Genomic Revolution ETF (BATS: ARKG) took an initial position in shares of...

Via Benzinga

Mindset Pharma, Cybin Among Top Psychedelic Movers Of Today ↗

February 08, 2022

GAINERS: Awakn Life Sciences (OTC:AWKNF) shares closed up 3.51% at $1.62

Via Benzinga

FDA Greenlight Sets the Stage for Upside With Mind Medicine ↗

February 08, 2022

Few catalysts can move healthcare stocks like a regulatory clearance can -- and MNMD stock could be 2022's top psychedelics-sector investment.

Via InvestorPlace

Mind Medicine, Small Pharma Among Top Psychedelic Movers Of Today ↗

February 07, 2022

GAINERS: Mind Medicine (NASDAQ:MNMD) shares closed up 9.82% at $1.23

Via Benzinga

Psychedelic Stocks Finally In An Upswing ↗

February 06, 2022

The Marijuana & Psychedelic Compounds-Based Drug Stocks Index went up +5.3% last week.

Via Talk Markets

Small Pharma, Mind Medicine Among Top Psychedelic Movers Of Today ↗

February 04, 2022

GAINERS: Small Pharma (OTC:DMTTF) shares closed up 7.29% at $0.20

Via Benzinga

Field Trip Health, Seelos Therapeutics Among Top Psychedelic Movers Of Today ↗

February 03, 2022

GAINERS: Small Pharma (OTC:DMTTF) shares closed up 6.29% at $0.19

Via Benzinga

Mind Medicine, Allied Among Top Psychedelic Movers Of Today ↗

February 02, 2022

GAINERS: Small Pharma (OTC:DMTTF) shares closed up 5.04% at $0.17

Via Benzinga

New Psychedelics ETF Launches On NYSE Arca ↗

February 02, 2022

Elemental Advisors Inc. has launched its first ETF, composed of companies involved in research, development, production or use of psychedelics to address medical conditions. The PSYK ETF (NYSE: PSYK)...

Via Benzinga

Mindset Pharma, Allied Among Top Psychedelic Movers Of Today ↗

February 01, 2022

GAINERS: Mindset Pharma (OTC:MSSTF) shares closed up 15.70% at $0.69

Via Benzinga

ATAI Life Sciences, Mind Medicine Among Top Psychedelic Movers Of Today ↗

January 31, 2022

GAINERS: ATAI Life Sciences (NASDAQ:ATAI) shares closed up 7.89% at $5.33

Via Benzinga

The Psychedelic & Marijuana Drug Stocks Index Dropped -30% In January ↗

January 30, 2022

This article updates the performances of 16 clinical-stage psychedelic and marijuana drug companies researching the treatment of a wide variety of mental illnesses.

Via Talk Markets

< Previous 1 2

...

24 25 26 27 28 29 30 31 32

...

34 35 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.